0001562180-22-007790.txt : 20221118 0001562180-22-007790.hdr.sgml : 20221118 20221118183123 ACCESSION NUMBER: 0001562180-22-007790 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221108 FILED AS OF DATE: 20221118 DATE AS OF CHANGE: 20221118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clark George C. CENTRAL INDEX KEY: 0001878290 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41477 FILM NUMBER: 221403137 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Ltd. CENTRAL INDEX KEY: 0001935979 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 FORMER COMPANY: FORMER CONFORMED NAME: Biohaven Research Ltd. DATE OF NAME CHANGE: 20220629 3 1 primarydocument.xml PRIMARY DOCUMENT X0206 3 2022-11-08 0 0001935979 Biohaven Ltd. BHVN 0001878290 Clark George C. C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 false true false false VP, Chief Accounting Officer Common Shares 61285.00 D Common Shares 3000.00 I By IRA Stock Options (Right to buy) 7.00 2032-10-03 Common Shares 185715.00 D The shares underlying this option became exercisable as to 50,000 of these shares on October 3, 2022, with the remainder vesting in 3 equal installments on October 3, 2023, 2024, and 2025, subject to the reporting person's continuing service as of each applicable vesting date. /s/ George Clark 2022-11-18